LeMaitre Vascular (LMAT) last issued guidance on February 25, 2026 for fiscal year 2026. The company guided earnings per share in the range of $2.81 - $3.01, compared to a consensus EPS estimate of $2.61. LeMaitre Vascular also guided revenue in the range of $276.00M - $284.00M for the period.
Compared to prior guidance, LeMaitre Vascular raised its revenue forecast from a prior range of $65.60M - $67.60M.
LeMaitre Vascular has issued 34 guidance updates between April 28, 2022 and February 25, 2026. During this period, the company raised its outlook 17 times and lowered it 16 times, providing investors with insight into management's evolving expectations.
Review all historical guidance issued by LeMaitre Vascular, including EPS and revenue forecasts across quarterly and annual periods.
The most recent guidance for LeMaitre Vascular (LMAT) was reported on February 25, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $2.81 to $3.01, compared to the estimated EPS of $2.61. Additionally, LeMaitre Vascular forecasted revenue between $276.00M and $284.00M for the period.
LeMaitre Vascular (LMAT) guided EPS in the range of $2.81 to $3.01 for the fiscal year 2026. The consensus analyst EPS estimate is $2.61.
LeMaitre Vascular (LMAT) guided revenue in the range of $276.00M to $284.00M for the fiscal year 2026.
LeMaitre Vascular (LMAT) raised its revenue guidance from a prior range of $65.60M - $67.60M to $276.00M - $284.00M for the fiscal year 2026.
LeMaitre Vascular (LMAT) last issued guidance on February 25, 2026 for the fiscal year 2026.